These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 9823902)

  • 21. [Toward more understanding of esophagogastric cancer].
    Xu JM
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):801-3. PubMed ID: 22335942
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adenocarcinoma of the esophagogastric junction (AEG-tumor). Review of the literature].
    Pilco J; Stein J
    Rev Gastroenterol Peru; 2006; 26(2):194-9. PubMed ID: 16865166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenocarcinomas of the distal esophagus and "gastric cardia" are predominantly esophageal carcinomas.
    Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
    Am J Surg Pathol; 2007 Apr; 31(4):569-75. PubMed ID: 17414104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of adenocarcinoma of the esophagogastric junction.
    Keeney S; Bauer TL
    Surg Oncol Clin N Am; 2006 Oct; 15(4):687-96. PubMed ID: 17030267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclassification of superficial cardia cancer in relation to the endoscopic esophagogastric junction.
    Jin L; Yoshida M; Kitagawa Y; Saikawa Y; Takeuchi H; Wada N; Kumai K; Kubota T; Kitajima M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S273-7. PubMed ID: 19120911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer.
    Siewert JR; Feith M
    J Am Coll Surg; 2007 Oct; 205(4 Suppl):S49-53. PubMed ID: 17916519
    [No Abstract]   [Full Text] [Related]  

  • 27. [Association of secondary short esophagus and adenocarcinoma of the esophagogastric junction].
    Angeletti CA; Mussi A; Janni A
    Minerva Chir; 1980 Sep; 35(17):1279-82. PubMed ID: 7231709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New proposal for postsurgery pathologic staging of esophageal or gastroesophageal junction adenocarcinoma: why bother?
    Ajani JA
    J Clin Oncol; 2007 Mar; 25(7):906-7; author reply 908-9. PubMed ID: 17327615
    [No Abstract]   [Full Text] [Related]  

  • 29. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
    Feith M; Stein HJ; Siewert JR
    Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates.
    Lindblad M; Ye W; Lindgren A; Lagergren J
    Ann Surg; 2006 Apr; 243(4):479-85. PubMed ID: 16552198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence.
    Forman D
    J Natl Cancer Inst; 2005 Jul; 97(13):1013-4; author reply 1014. PubMed ID: 15998956
    [No Abstract]   [Full Text] [Related]  

  • 32. AEG I and II: is it one tumor entity?
    Lenglinger J; Ringhofer C; Riegler M
    Ann Surg; 2008 Jun; 247(6):1080-1; author reply 1081. PubMed ID: 18520245
    [No Abstract]   [Full Text] [Related]  

  • 33. Transition in biology and philosophy in the treatment of gastroesophageal junction adenocarcinoma.
    Tepper JE; O'Neil B
    J Clin Oncol; 2009 Feb; 27(6):836-7. PubMed ID: 19139425
    [No Abstract]   [Full Text] [Related]  

  • 34. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
    Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
    J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
    [No Abstract]   [Full Text] [Related]  

  • 35. [Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
    Créhange G; Bonnetain F; Chauffert B; Rat P; Bedenne L; Maingon P
    Cancer Radiother; 2008 Sep; 12(5):365-73. PubMed ID: 18420440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multidisciplinary management of gastrointestinal cancer. Epidemiology of oesophagogastric cancer.
    Lambert R; Hainaut P
    Best Pract Res Clin Gastroenterol; 2007; 21(6):921-45. PubMed ID: 18070696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification of tumors of the esophagus and stomach (WHO 1990). Part II: tumors of the stomach].
    Bogomoletz WV
    Ann Pathol; 1993; 13(4):279-80. PubMed ID: 8280309
    [No Abstract]   [Full Text] [Related]  

  • 40. Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia.
    McColl KE; Going JJ
    Gut; 2010 Mar; 59(3):282-4. PubMed ID: 20207629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.